The proportion of tumor-associated CD4+ and CD8+ T cells as a percentage of all immune cells from B16 tumors isolated from miR-301a−/− mice was higher than those from WT mice (Fig. 6j and k). This evidence concerns the gene CD4 and neoplasm.